These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22975583)

  • 41. Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis.
    Afify SM; Tabll A; Nawara HM; El Kassas M; Elfert A; Seno M; El-Kousy S
    Clin Lab; 2018 Oct; 64(10):1685-1693. PubMed ID: 30336529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
    Li X; Xu H; Gao P
    Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients.
    Kim HY; Jin EH; Kim W; Lee JY; Woo H; Oh S; Seo JY; Oh HS; Chung KH; Jung YJ; Kim D; Kim BG; Lee KL
    Medicine (Baltimore); 2015 Jun; 94(24):e1031. PubMed ID: 26091449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Deng H; Qi X; Guo X
    Medicine (Baltimore); 2015 Oct; 94(42):e1795. PubMed ID: 26496312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
    Giannini E; Risso D; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Testa E; Ceppa P; Testa R
    Arch Intern Med; 2003 Jan; 163(2):218-24. PubMed ID: 12546613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S; Memon MS; Ghani H; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic analysis of esophageal varices in patients with liver cirrhosis using color Doppler ultrasound.
    Li FH; Hao J; Xia JG; Li HL; Fang H
    World J Gastroenterol; 2005 Aug; 11(29):4560-5. PubMed ID: 16052688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PLATELET COUNT SQUARED/SPLEEN DIAMETER-ASPARTATE AMINOTRANSFERASE RATIO: NON-INVASIVE METHOD TO PREDICT ESOPHAGEAL VARICES.
    Mattos ÂZ; Daros LF; Mattos AA
    Arq Gastroenterol; 2017; 54(3):222-224. PubMed ID: 28591243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Albumin and magnetic resonance imaging-liver volume to identify hepatitis B-related cirrhosis and esophageal varices.
    Li H; Chen TW; Li ZL; Zhang XM; Li CJ; Chen XL; Chen GW; Hu JN; Ye YQ
    World J Gastroenterol; 2015 Jan; 21(3):988-96. PubMed ID: 25624735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis.
    Ibrahim EH; Marzouk SA; Zeid AE; Lashen SA; Taher TM
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):241-247. PubMed ID: 30281535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
    Imperiale TF; Said AT; Cummings OW; Born LJ
    Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.
    Shah AG; Smith PG; Sterling RK
    Dig Dis Sci; 2011 Oct; 56(10):3038-44. PubMed ID: 21526398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.
    Sanai FM; Farah T; Albeladi K; Batwa F; Dahlan Y; Babatin MA; Al-Ashgar H; AlMana H; Alsaad KS; AlSwat K; Aljumah A; AlTraif IH; Kailani BE; Bzeizi KI
    BMC Gastroenterol; 2017 Aug; 17(1):101. PubMed ID: 28841822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
    Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
    Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding.
    Liu TT; Wong WJ; Hou MC; Lin HC; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2006 May; 21(5):908-13. PubMed ID: 16704544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
    Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
    Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
    Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases.
    Liu CH; Lin JW; Tsai FC; Yang PM; Lai MY; Chen JH; Kao JH; Chen DS
    Liver Int; 2006 Nov; 26(9):1087-94. PubMed ID: 17032409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.